trial · primary record
Placebo
Type 2 Diabetes
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 600 |
| Primary completion | 2028-05-01 |
| Primary endpoint | Absolute change in glycosylated haemoglobin A1c (HbA1c) (%) from baseline to Week 41 |
| Registry ID | NCT07754461 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:05.799Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07754461
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Placebo · compound